Sight Sciences (SGHT) Fundamental Analysis: Revenue, Earnings & Valuation

1.03 / 10

Underperform

Fundamental rating is Underperform with a 1/10 positioning. Profit‑MV and net‑profit‑to‑total‑profit ratios are relatively strong, yet Revenue‑MV, Cash‑MV and ROA are negative, indicating poor revenue generation and cash strength. Overall, the company’s financial health appears fragile.

Analysis Checks(2/10)

Revenue-MV

Value-1.19

Score0/3

Weight46.73%

1M Return-4.18%

ROA (%)

Value-29.77

Score1/3

Weight9.74%

1M Return-0.82%

Net cash flow from operating activities / Operating revenue (%)

Value-38.38

Score1/3

Weight15.36%

1M Return-1.35%

Profit-MV

Value0.66

Score2/3

Weight-44.13%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-29.77

Score1/3

Weight9.74%

1M Return-0.82%

EBIT / Total operating revenue (%)

Value-48.15

Score1/3

Weight8.68%

1M Return-0.83%

Asset-MV

Value-0.55

Score1/3

Weight-4.71%

1M Return0.38%

Net profit / Total operating revenue (%)

Value-49.67

Score1/3

Weight9.92%

1M Return-0.84%

Cash-MV

Value0.02

Score1/3

Weight41.84%

1M Return-4.16%

Net profit / Total profit (%)

Value100.03

Score2/3

Weight6.84%

1M Return-0.54%

Is SGHT undervalued or overvalued?

SGHT scores 1.03/10 on fundamentals and holds a Premium valuation at present. Backed by its -50.74% ROE, -49.67% net margin, -5.14 P/E ratio, 3.09 P/B ratio, and 28.16% earnings growth, these metrics solidify its Underperform investment rating.